CLINICAL_TRIALS
trial_result
· 2012-07-02
Clinical Trial Update: A Dose-Ranging Study Evaluating the Safety and Efficacy of IDP-107 in Patients With Acne Vulgaris [Phase 2]
Summary
Completed Phase 2 dose-ranging trial evaluating safety and efficacy of IDP-107 for acne vulgaris.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Dow Pharmaceutical Sciences | Conditions: Acne Vulgaris | Phase 2 | Status: COMPLETED